TENX Message Board Post 9039012 | Tenax Therapeutics Inc.
home / stock / tenx / tenx message board
KevGardner
(investorshub)
Posted on: Mar/30/2023 05:36:49
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171573732
Is thing ever going to move
News, Short Squeeze, Breakout and More Instantly...
-
Currently Enrolling Patients in Phase 3 LEVEL Study with 24 Investigative Sites Initiated Secured Global Development and Commercial Rights to Levosimendan for Treatment of PH-HFpEF Expanded Intellectual Property Estate for Levosimendan with Issuance of New U.S. Patent ...
-
Broadens IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active metabolites (OR1896 and OR1855), in PH-HFpEF Provides U.S. intellectual property (IP) protection until December 2040, and may qualify for additional U.S. patent term extension (PTE) beyond ...